LIVE ONLINE Conference Programme



Integrative Oncology

06 Nov 2021
Integrative Oncology

(Timings are in Greenwich Mean Time - add session to your diary using link below)

TriCAM - Results of a pilot RCT on CAM during allogeneic stem cell transplantation

Introduction: Allogeneic Stem Cell Transplantation (aSCT) is the only curative therapy for many hematological malignancies such as leukemia. Patients undergoing aSCT have a 30-70% chance of developing acute Graft versus Host disease (aGvHD), often with severe and lasting physical and emotional impairments leading to depression and poor quality of life (QoL), despite extensive research for preventive strategies. In this pilot study,the effects of an integrative approach on QoL and on the adverse effects during the course of aSCT were  investigated.


Dr Ali Behzad, Physician, University Hospital of Erlangen - Germany

The joint congress for ESIM and ISCMR:

Organised in association with:

Gold Sponsors:


Silver Sponsors:


Supported by: